U.S. COMPANY FILING
BRISTOL MYERS SQUIBB CO — Form 10-Q filed 2026-04-30
Filing text preview
Bristol Myers Squibb reported Q1 2026 total revenues of $11,489 million, up 2.6% YoY, and net earnings of $2,678 million, up 8.8%. R&D expenses increased, while amortization decreased. The company continues restructuring and faces Eliquis patent litigation.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record